Ritiu, S.A.; Baloi, A.; Păpurică, M.; Sandesc, D.; Toma, D.; Bârsac, C.R.; Popovici, S.E.; Butaș, M.; Botoaca, A.-M.-I.; Bedreag, O.
Real-World Use of Cefiderocol for Multidrug-Resistant Gram-Negative Infections in Critically Ill ICU Patients: A Single-Center Case Series. Pathogens 2026, 15, 786.
https://doi.org/10.3390/pathogens15080786
AMA Style
Ritiu SA, Baloi A, Păpurică M, Sandesc D, Toma D, Bârsac CR, Popovici SE, Butaș M, Botoaca A-M-I, Bedreag O.
Real-World Use of Cefiderocol for Multidrug-Resistant Gram-Negative Infections in Critically Ill ICU Patients: A Single-Center Case Series. Pathogens. 2026; 15(8):786.
https://doi.org/10.3390/pathogens15080786
Chicago/Turabian Style
Ritiu, Stelian Adrian, Adelina Baloi, Marius Păpurică, Dorel Sandesc, Daiana Toma, Claudiu Rafael Bârsac, Sonia Elena Popovici, Madalina Butaș, Ana-Maria-Ionela Botoaca, and Ovidiu Bedreag.
2026. "Real-World Use of Cefiderocol for Multidrug-Resistant Gram-Negative Infections in Critically Ill ICU Patients: A Single-Center Case Series" Pathogens 15, no. 8: 786.
https://doi.org/10.3390/pathogens15080786
APA Style
Ritiu, S. A., Baloi, A., Păpurică, M., Sandesc, D., Toma, D., Bârsac, C. R., Popovici, S. E., Butaș, M., Botoaca, A.-M.-I., & Bedreag, O.
(2026). Real-World Use of Cefiderocol for Multidrug-Resistant Gram-Negative Infections in Critically Ill ICU Patients: A Single-Center Case Series. Pathogens, 15(8), 786.
https://doi.org/10.3390/pathogens15080786